1.
Tech Vasc Interv Radiol
; 26(2): 100900, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37865450
RESUMO
Treating cancer patients with deep venous thrombosis/venous thromboembolism (DVT/VTE) can be challenging as patients are frequently unable to receive the standard therapy of anticoagulation due to the increased risk of bleeding complications seen in this population. Similarly, the hesitation of interventionalists to use thrombolytic agents due to bleeding risks limits percutaneous intervention options as well. Further, outcome data and guidelines do not exist for oncologic patients and often treatment is tailored to patient-specific factors after multidisciplinary discussion. This article reviews specific factors to consider when planning percutaneous treatment of cancer patients with DVT/VTE, focusing on the iliocaval system.
Assuntos
Neoplasias , Tromboembolia Venosa , Trombose Venosa , Humanos , Terapia Trombolítica/efeitos adversos , Trombose Venosa/diagnóstico por imagem , Trombose Venosa/terapia , Tromboembolia Venosa/terapia , Anticoagulantes/efeitos adversos , Trombectomia/efeitos adversos , Catéteres/efeitos adversos , Resultado do Tratamento , Neoplasias/complicações , Neoplasias/terapia
2.
Cardiovasc Intervent Radiol
; 45(8): 1225-1227, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35581474